Bacteria to Do Our Bidding

12/27/11

[Editor's note: We asked a group of Xconomists to answer the following question: "If you could patent one thing, what would it be?"]

Broad claims covering delivery of therapeutics using engineered bacteria. Synthetic biology tools emerging in just the last few years have made this possible. The trick, of course, is precise control. If I could patent a sure-fire control technology enabling precise delivery of drugs and biologics through living organisms such as bacteria, I would quit my day job.

Matthew O'Donnell is the Dean of the University of Washington's College of Engineering. Follow @

By posting a comment, you agree to our terms and conditions.